Table 1 Demographic details and treatment characteristics of the study
Characteristics | Entire cohort (N = 144) |
|---|---|
Median age (range) | 45 years (18–85 years) |
Sex (male: female) | 123: 21 |
Addiction | |
No addiction | 17 (12%) |
Tobacco chewer | 98 (68%) |
Tobacco smoker | 34 (24%) |
Alcohol and smoking both | 08 (06%) |
Neo-adjuvant chemotherapy (NACT) | |
Yes | 08 (06%) |
No | 136 (94%) |
Clinical stage of disease (AJCC 7th) | |
Stage I | 12 (08%) |
Stage II | 30 (21%) |
Stage III | 29 (20%) |
Stage IV | 23 (16%) |
Unknown | 50 (35%) |
Glossectomy | |
With L.N. dissection | 141 (98%) |
Without L.N dissection | 03 (02%) |
Extent of L.N. dissection (N = 141) | |
Ipsilateral | 117 (83%) |
Bilateral | 24 (16%) |
Unknown | 02 (01) |
Pathological stage of disease (AJCC 7th) | |
Stage I | 26 (18%) |
Stage II | 21 (15%) |
Stage III | 29 (20%) |
Stage IV | 66 (46%) |
Unknown | 02 (01%) |
Pathological stage of disease (AJCC 8th) | |
Stage I | 07 (05%) |
Stage II | 17 (12%) |
Stage III | 33 (23%) |
Stage IV | 76 (53%) |
Unknown | 11 (07%) |
Dose of RT (median) | 60Gy (50-70) |
Concurrent chemotherapy | |
Yes | 57 (40%) |
No | 80 (55%) |
Unknown | 07 (05%) |